Global Exosome Diagnostics Market is Projected to Boom with an Enormous CAGR of ~47% by 2032 | DelveInsight
16 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Global Exosome Diagnostics Market is Projected to Boom with an Enormous CAGR of ~47% by 2032 | DelveInsight The rising incidence of cancer is...
Liver Cirrhosis Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 30+ Companies Working in the Domain
15 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Liver Cirrhosis Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 30+ Companies Working in the...
Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight
14 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis,...
Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
13 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Therapeutics Segment |...
Rare Endocrinology and Metabolic Disorders Market Analysis: Emerging Trends and Future Outlook of Hypophosphatasia, Congenital Adrenal Hyperplasia, and Severe Hypertriglyceridemia | DelveInsight
09 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Rare Endocrinology and Metabolic Disorders Market Analysis: Emerging Trends and Future Outlook of Hypophosphatasia, Congenital Adrenal Hyperplasia,...
Latest Published 4 Rare Neurological Disorders Market Reports by DelveInsight: Amyotrophic Lateral Sclerosis, Developmental and Epileptic Encephalopathies, Primary Ciliary Dyskinesia, and Chronic Inflammatory Demyelinating Polyneuropathy
09 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Latest Published 4 Rare Neurological Disorders Market Reports by DelveInsight: Amyotrophic Lateral Sclerosis, Developmental and Epileptic...
Stay Ahead in Ophthalmology: Strategic Market Insights for Myopia Assessment & Forecasting | DelveInsight
20 déc. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Stay Ahead in Ophthalmology: Strategic Market Insights for Myopia Assessment & Forecasting | DelveInsight A case study on how a leading company...
Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight
19 déc. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight Rare genetic disorders affect approximately 1 in...
MET Targeting Therapies Market Set for Significant Growth by 2034: Key Trends and Insights | DelveInsight
18 déc. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Dec. 18, 2024 (GLOBE NEWSWIRE) -- MET Targeting Therapies Market Set for Significant Growth by 2034: Key Trends and Insights | DelveInsight The MET targeting therapies market is...
Rare Skin Disorders Market: Key Insights into Future Outlook and Trends of Pemphigus Vulgaris, Epidermolysis Bullosa, Palmoplantar Pustulosis, and Prurigo Nodularis | DelveInsight
17 déc. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Rare Skin Disorders Market: Key Insights into Future Outlook and Trends of Pemphigus Vulgaris, Epidermolysis Bullosa, Palmoplantar Pustulosis, and...